Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The gel combining minoxidil and Aloe vera could be an effective, non-irritating treatment for hair loss.

The model and estimator can predict drug exposure in kidney transplant patients well.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.